Nuveen Asset Management LLC lowered its stake in shares of Danaher Co. (NYSE:DHR) by 8.5% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,589,728 shares of the conglomerate’s stock after selling 333,355 shares during the quarter. Nuveen Asset Management LLC’s holdings in Danaher were worth $634,772,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also bought and sold shares of DHR. Swedbank acquired a new stake in Danaher during the 1st quarter worth approximately $141,809,000. Fisher Asset Management LLC increased its position in Danaher by 49.1% during the 2nd quarter. Fisher Asset Management LLC now owns 2,801,341 shares of the conglomerate’s stock worth $495,361,000 after purchasing an additional 922,949 shares in the last quarter. Viking Global Investors LP acquired a new stake in Danaher during the 2nd quarter worth approximately $159,842,000. Capital International Investors increased its position in Danaher by 10.0% during the 1st quarter. Capital International Investors now owns 6,802,713 shares of the conglomerate’s stock worth $941,564,000 after purchasing an additional 619,550 shares in the last quarter. Finally, Swiss National Bank increased its position in Danaher by 21.3% during the 1st quarter. Swiss National Bank now owns 2,778,920 shares of the conglomerate’s stock worth $384,630,000 after purchasing an additional 488,000 shares in the last quarter. 78.01% of the stock is owned by hedge funds and other institutional investors.
DHR has been the subject of several recent research reports. Needham & Company LLC increased their price objective on shares of Danaher from $183.00 to $209.00 and gave the company a “buy” rating in a research report on Monday, July 27th. Bank of America increased their price objective on shares of Danaher from $181.00 to $215.00 and gave the company a “buy” rating in a research report on Monday, July 20th. Stifel Nicolaus increased their price objective on shares of Danaher from $170.00 to $210.00 and gave the company a “hold” rating in a research report on Friday, July 24th. Zacks Investment Research raised shares of Danaher from a “hold” rating to a “buy” rating and set a $203.00 price objective for the company in a research report on Tuesday, July 21st. Finally, Wolfe Research raised shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $195.00 price objective for the company in a research report on Tuesday, June 16th. Two analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $197.73.
Danaher (NYSE:DHR) last announced its quarterly earnings data on Thursday, July 23rd. The conglomerate reported $1.44 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.09 by $0.35. Danaher had a return on equity of 11.88% and a net margin of 17.73%. The firm had revenue of $5.30 billion for the quarter, compared to analysts’ expectations of $5.01 billion. During the same period last year, the business posted $1.09 earnings per share. The firm’s revenue for the quarter was up 2.7% on a year-over-year basis. Sell-side analysts expect that Danaher Co. will post 5.47 EPS for the current year.
In other Danaher news, SVP Angela S. Lalor sold 38,954 shares of the firm’s stock in a transaction on Friday, August 28th. The stock was sold at an average price of $205.00, for a total value of $7,985,570.00. Following the sale, the senior vice president now directly owns 52,445 shares in the company, valued at $10,751,225. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Angela S. Lalor sold 77,909 shares of the firm’s stock in a transaction on Monday, August 31st. The shares were sold at an average price of $205.50, for a total value of $16,010,299.50. Following the completion of the sale, the senior vice president now owns 52,445 shares in the company, valued at $10,777,447.50. The disclosure for this sale can be found here. Insiders sold 530,474 shares of company stock worth $104,501,669 over the last quarter. 11.70% of the stock is currently owned by company insiders.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Featured Article: How are dividend achievers different from dividend aristocrats?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.